Arlington Capital Partners acquires majority stake in Riverpoint Medical

Arlington Capital Partners has acquired a majority interest in Riverpoint Medical, a developer and manufacturer of advanced sutures, implantables, and surgical devices. The transaction was advised by The Walden Group.

“The Walden Group, Inc. is pleased to announce that Arlington Capital Partners has acquired a majority interest in its client, Riverpoint Medical, LLC.”waldenmed.com

• 1 source
• waldenmed.comThe Walden Group advises Riverpoint Medical, LLC in its Partnership with Arlington Capital Partners and Helps Guide the Transaction to a Successful Closing - Walden GroupJul 22, 2019

Summarized from public sources; check the original articles before acting on it.